These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30761180)

  • 1. Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer.
    Wang C; Liu Z; Ke Y; Wang F
    Front Genet; 2019; 10():12. PubMed ID: 30761180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
    Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
    J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1.
    Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL
    Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.
    Jin C; McKeehan K; Guo W; Jauma S; Ittmann MM; Foster B; Greenberg NM; McKeehan WL; Wang F
    Cancer Res; 2003 Dec; 63(24):8784-90. PubMed ID: 14695195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
    Feng S; Wang F; Matsubara A; Kan M; McKeehan WL
    Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine Fibroblast Growth Factor Initiates Oncogenic Synergy with Epithelial FGFR/Src Transformation in Prostate Tumor Progression.
    Li Q; Ingram L; Kim S; Beharry Z; Cooper JA; Cai H
    Neoplasia; 2018 Mar; 20(3):233-243. PubMed ID: 29444487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.
    Labanca E; Yang J; Shepherd PDA; Wan X; Starbuck MW; Guerra LD; Anselmino N; Bizzotto JA; Dong J; Chinnaiyan AM; Ravoori MK; Kundra V; Broom BM; Corn PG; Troncoso P; Gueron G; Logothethis CJ; Navone NM
    Eur Urol Oncol; 2022 Apr; 5(2):164-175. PubMed ID: 34774481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
    Katoh M
    Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia.
    Wang F; McKeehan K; Yu C; Ittmann M; McKeehan WL
    Prostate; 2004 Jan; 58(1):1-12. PubMed ID: 14673947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells.
    Fan Z; Ma J; Pan X; Zhao L; Wu Y; Lin H; Zhao Y; Jiang H; Pan T; Li X; Wang F; Wang C
    Int J Cancer; 2022 May; 150(9):1525-1536. PubMed ID: 34985768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2.
    Matsubara A; Kan M; Feng S; McKeehan WL
    Cancer Res; 1998 Apr; 58(7):1509-14. PubMed ID: 9537256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE
    Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor models for prostate cancer exemplified by fibroblast growth factor 8-induced tumorigenesis and tumor progression.
    Tuomela J; Härkönen P
    Reprod Biol; 2014 Mar; 14(1):16-24. PubMed ID: 24607251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis.
    Lin Y; Liu G; Zhang Y; Hu YP; Yu K; Lin C; McKeehan K; Xuan JW; Ornitz DM; Shen MM; Greenberg N; McKeehan WL; Wang F
    Development; 2007 Feb; 134(4):723-34. PubMed ID: 17215304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
    Naimi B; Latil A; Fournier G; Mangin P; Cussenot O; Berthon P
    Prostate; 2002 Aug; 52(3):245-52. PubMed ID: 12111699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer.
    Liu J; Chen G; Liu Z; Liu S; Cai Z; You P; Ke Y; Lai L; Huang Y; Gao H; Zhao L; Pelicano H; Huang P; McKeehan WL; Wu CL; Wang C; Zhong W; Wang F
    Cancer Res; 2018 Aug; 78(16):4459-4470. PubMed ID: 29891507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Biology of the FGF7 Subfamily.
    Zinkle A; Mohammadi M
    Front Genet; 2019; 10():102. PubMed ID: 30809251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles of mouse submandibular gland development: FGFR1 regulates branching morphogenesis in vitro through BMP- and FGF-dependent mechanisms.
    Hoffman MP; Kidder BL; Steinberg ZL; Lakhani S; Ho S; Kleinman HK; Larsen M
    Development; 2002 Dec; 129(24):5767-78. PubMed ID: 12421715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
    André F; Bachelot T; Campone M; Dalenc F; Perez-Garcia JM; Hurvitz SA; Turner N; Rugo H; Smith JW; Deudon S; Shi M; Zhang Y; Kay A; Porta DG; Yovine A; Baselga J
    Clin Cancer Res; 2013 Jul; 19(13):3693-702. PubMed ID: 23658459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.